Biotechnology Diabetes Scientists Reveal New Target for Anti-Lymphangiogenesis Drugs By Staff Reports 5 years ago After an injury to tissues, such as in organ transplantation, the body grows new lymphatic
Biotechnology Dysfunctional Endosomes Are An Early Sign of Neurodegeneration By Staff Reports 5 years ago Writing in the April 11 issue of The Journal of Clinical Investigation, researchers at University
Biotechnology Diabetes Solving a Genetic Mystery in Type 1 Diabetes By Staff Reports 5 years ago In type 1 diabetes, the immune system attacks the body’s own insulin-producing cells. Scientists understand
Biotechnology Pharmaceutical Business News Pharmaceuticals Q&A with Denis Corin, Q Bio Med Inc – Getting Past the “Pharma Bro” – Smaller Biotech Continue to Strive for Well-Being of Patients By Staff Reports 5 years ago There has been a vast amount of mixed feelings surrounding the biotech/drug company development of
Biotechnology Cell Therapy Growing skin in the lab By Staff Reports 5 years ago Using reprogrammed iPS cells, scientists from the RIKEN Center for Developmental Biology (CDB) in Japan
Biotechnology Diabetes Vaccines Salmonella-Based Oral Vaccine a Promising Therapy for Preventing Type 1 Diabetes By Staff Reports 5 years ago A combined vaccine therapy including live Salmonella is a safe and effective way to prevent
Biotechnology Gene Therapy Genomes Seeing Cell to Cell Differences for First Time Explains Symptoms of Rare Genetic Disorders By Staff Reports 5 years ago Every cell in the body has two genomes, one from the mother and one from
Biotechnology cancer Clinical Trials Radiopharmaceuticals FDA Greenlights Orphan Drug Status for Radioimmuneconjugate for Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients By Staff Reports 5 years ago The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a
Biotechnology Cell Therapy Clinical Trials Diabetes Sketches Of Progress By Staff Reports 5 years ago By Richard (Rick) Mills, Editor of Aheadoftheherd.com Disruptive innovations have the potential to truly reshape
Biotechnology Looking at the Bacteria Inside: A New Method of Viewing TB Bacteria By Staff Reports 5 years ago Although tuberculosis (TB) is commonly thought of as being a disease that mainly affects nineteenth
Biotechnology cancer Clinical Trials Cancer Immunotherapies take Center Stage By Staff Reports 5 years ago The newly created task force on cancer, in what Vice President Joe Biden has called
Biotechnology cancer Clinical Trials Many Targeted Cancer Therapies Suppress T Cell Immune Responses By Staff Reports 5 years ago In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery
Arthritis Biotechnology Clinical Trials Pharmaceuticals Prescriptions New Study Shows Common NSAIDs can cause more Harm than Good By Staff Reports 5 years ago Many patients around the world, are prescribed non-steroidal anti-inflammatory drugs (called NSAIDs) for the treatment